Fang Yu

Fang Yu

Auto-generated profile, based on publicly available information

Fang Yu

Department of Medicine, University of Florida Health Cancer Center and

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FYFang Yu
Fang Yu
SZShikan Zheng
Shikan Zheng
CYChunjie Yu
Chunjie Yu
SGSanhui Gao
Sanhui Gao
ZSZuqi Shen
Zuqi Shen
ZQZhijian Qian
Zhijian Qian
Constitutively active mutations of KRAS are prevalent in non–small cell lung cancer (NSCLC). However, the relationship between these mutations and resistance to platinum-based chemotherapy and the underlying mechanisms remain elusive. In this study, we demonstrate that KRAS mutants confer resistance to platinum in NSCLC. Mechanistically, KRAS mutants mediate platinum resistance in NSCLC cells by activating ERK/JNK signaling, which inhibits AlkB homolog 5 (ALKBH5) N 6 -methyladenosine (m 6 A) demethylase activity by regulating posttranslational modifications (PTMs) of ALKBH5. Consequently, the KRAS mutant leads to a global increase in m 6 A methylation of mRNAs, particularly damage-specific DNA-binding protein 2 ( DDB2 ) and XPC , which are essential for nucleotide excision repair. This methylation stabilized the mRNA of these 2 genes, thus enhancing NSCLC cells’ capability to repair platinum-induced DNA damage and avoid apoptosis, thereby contributing to drug resistance. Furthermore, blocking KRAS-mutant–induced m 6 A methylation, either by overexpressing a SUMOylation-deficient mutant of ALKBH5 or by inhibiting methyltransferase-like 3 (METTL3) pharmacologically, significantly sensitizes KRAS -mutant NSCLC cells to platinum drugs in vitro and in vivo. Collectively, our study uncovers a mechanism that mediates KRAS-mutant–induced chemoresistance in NSCLC cells by activating DNA repair through the modulation of the ERK/JNK/ALKBH5 PTM-induced m 6 A modification in DNA damage repair–related genes.

31 January 2024 in STAR Protocols
Verified
Journal Article
Open access
FYFang Yu
Fang Yu
SLShun Liu
Shun Liu
AZAllen C. Zhu
Allen C. Zhu
CHChuan He
Chuan He
ZQZhijian Qian
Zhijian Qian
RNA-binding proteins (RBPs) regulate gene expression both co-transcriptionally and post-transcriptionally. Here, we provide a protocol for photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation followed by next-generation sequencing (PAR-CLIP-seq). PAR-CLIP-seq is a transcriptome-scale technique for identifying in vivo binding sites of RBPs at the single-nucleotide level. We detail procedures for the establishment of FLAG-RBM33 stable cell line, the sequencing library preparation, and the data analysis.